Learning Objectives: -Assess the current clinical unmet needs across heme malignancies to support the role of new and emerging therapeutic strategies, including high-risk and vulnerable patient populations. -Apply guideline-concordant, evidence-based approaches to risk stratification and prognostic assessment to support timely diagnosis, optimize treatment selection, and improve patient outcomes. -Evaluate recent data on current and emerging therapies and regimens, including monotherapy and combinations, in consideration of efficacy, safety, toxicity management, sequencing, and real-world implementation. -Differentiate novel and emerging therapies by mechanism of action, indication, administration, and impact on quality of life for patients with heme malignancies. -Select appropriate therapy in consideration of disease-, patient-, and treatment-related factors to develop personalized management plans for patients with heme malignancies. -Incorporate patient-centered approaches such as patient education and shared decision-making to align treatment plans in consideration of patient preferences and barriers to enhance the quality of care for individuals with heme malignancies.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership · $19.99/mo
| Regular Membership | Free |
| Affiliated Health Professional Membership | Free |
| MENASA Group Explorer | Free |
| MENASA Group Elite Member | $19.99/mo |
Collected from the provider’s public pages · source
Specialties served/covered
- Cardiovascular Disease
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Medical Oncology
- Metabolic & Bariatric Surgery
- Nephrology
- Neurology
- Neuroradiology
- Ophthalmology
- Patient Education & Health Literacy
- Pediatric Gastroenterology
- Practice Management & Ethics
- Pulmonary Disease
- Sleep Medicine
- Thoracic Surgery
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- Surgery
- No reviews yet. Be the first to share yours.
- On-demand / recorded video
- includes Article / monograph / reference
- Credit · Up to 30 credits
- MOC · Up to 30 points
- Fee · varies
- Commercial Support
-
ReleasedSep 9, 2026
-
Last day to claim creditDec 10, 2026 8 weeks left
-
Medscape, LLC Highlights in Hematologic Malignancies From the 2025 Winter Meeting
-
Clinical Care Options, LLC (dba Decera Clinical Education) Decoding Discoveries in Hematologic Malignancies Decera Clinical Education’s Independent Highlights of the 2026 ASCO and EHA Conferences
-
Plexus Communications +1 Targeting CD19 for DLBCL and FL: Beyond CAR T-Cells
-
Medical Learning Institute, Inc. Advancing Care in Myeloproliferative Neoplasms: From Established Standards to Future Treatment Paradigms
-
Blood Cancer United +1 Inside Myeloma Rounds: Expert Discussion and Updates
-
Medical Learning Institute, Inc. Preserving Liver Function, Improving Long-term Survival & Enhancing Quality of Life in Patients with HCC
